INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

People assigned to a diet, food or program and measured.

593 studies · page 6 of 25

2016 / Double-blind, randomized, placebo-controlled trial

In sedentary adults, daily dark chocolate intake for 3 months increased maximum work, improved muscle markers, and raised HDL levels.

Twenty sedentary adults aged ~50 were randomized to consume 20 g of dark chocolate or placebo daily for 3 months, with 17 completing the study. In the dark chocolate group (n = 9), VO2 max showed a 17% increase (p = 0.056) and maximum work achieved increased significantly (p = 0.026), alongside higher HDL (p = 0.005) and decreased triglycerides (p = 0.07), with no changes in placebo (n = 8). Skeletal muscle showed significant increases in LKB1, AMPK, and PGC1α proteins and their active forms, citrate synthase activity, and reduced glutathione, as well as decreased protein carbonylation, without changes in mitochondrial density. The authors note larger clinical studies are warranted to confirm these observations.

Taub PR, Ramirez-Sanchez I, Patel M, et al. Food Funct, 2016. PMID 27491778

2016 / Randomized controlled trial

Flaxseed reduced central blood pressure in participants with high baseline blood pressure.

Among 62 patients with peripheral artery disease who had high blood pressure at baseline, dietary flaxseed lowered central systolic and diastolic blood pressures by an average of 10 and 6 mm Hg compared to placebo. Flaxseed did not significantly alter the augmentation index or other cardiac function indices. The reduction in central blood pressure was linked to decreases in specific plasma oxylipins, including 16-hydroxyeicosatetraenoic acid and thromboxane B2.

Caligiuri SP, Rodriguez-Leyva D, Aukema HM, et al. Hypertension, 2016. PMID 27528063

2016 / Randomized crossover trial

Acute açai smoothie consumption improved flow-mediated dilatation and reduced oxidative status in men.

In a randomized double-blind crossover trial of 23 overweight men given a high-fat breakfast challenge, an açai smoothie increased flow-mediated dilatation by 1.4% at 2 hours and 0.8% at 6 hours, versus 0.4% and -0.3% for control. The açai beverage also lowered postprandial total peroxide oxidative status. Blood pressure, heart rate, and glucose remained unchanged, whereas early insulin peaks and overall post-meal insulin exposure were higher following açai.

Alqurashi RM, Galante LA, Rowland IR, et al. Am J Clin Nutr, 2016. PMID 27680990

2016 / 8-week randomized, double-blind, placebo-controlled trial

Anthocyanin-rich black soybean testa extract improved abdominal fat measurements and lipid profiles in overweight or obese Korean adults.

Sixty-three overweight or obese Korean adults were randomized to receive either 2.5 g/d of anthocyanin-rich black soybean testa extract (BBT, n=32) or placebo (2.5 g/d starch, n=31) for 8 weeks. The BBT group experienced significant decreases in abdominal fat (waist circumference and hip circumference) as well as reductions in triacylglycerols, LDL cholesterol, and non-HDL cholesterol. Arteriosclerosis indicators (TC/HDLc and LDLc/HDLc) also significantly decreased in the BBT group but remained unchanged in the placebo group, with no differences observed between groups in energy-adjusted dietary intakes or physical activity.

Lee M, Sorn SR, Park Y, et al. J Med Food, 2016. PMID 27809637

2015 / Pooled analysis of randomized controlled trials

Six months of soy food or isoflavone intake did not elevate uric acid.

A pooled analysis evaluated two 6-month randomized trials involving 450 postmenopausal women with prehypertension or prediabetes. Compared with milk placebo, participants receiving combined soy foods had a smaller decline in serum uric acid, resulting in a net difference of 14.5 micromol/L (95% CI: 1.93-25.6, p = 0.023) or 4.9% (95% CI: 1.3-8.5%, p = 0.023). Soy foods did not raise absolute urate levels.

Liu ZM, Ho CS, Chen YM, et al. Eur J Nutr, 2015. PMID 24659208

2015 / Controlled trial

A modified portfolio diet reduced LDL cholesterol and improved endothelial function in diabetic patients after bypass surgery.

Thirty patients with type II diabetes 6 weeks post-bypass surgery received counseling on a Modified Portfolio Diet (MPD) including low fat, viscous fibers, soy protein, and almonds, while 7 patients with no diet therapy served as time controls. Consumption of the MPD led to a 19% relative reduction in LDL cholesterol (1.9 ± 0.8 vs 1.6 ± 0.6 mmol/L, p < 0.001) with no change in HDL cholesterol, and homocysteine levels dropped (10.1 ± 2.7 vs 7.9 ± 4 μmol/L, p = 0.006). Flow-mediated dilatation increased from 3.8 ± 3.8% to 6.5 ± 3.6% (p = 0.004) in treated patients while remaining constant in controls (p = 0.6), and endothelial progenitor cell numbers increased significantly (p < 0.02). Time controls showed no significant changes across these measures.

Keith M, Kuliszewski MA, Liao C, et al. Clin Nutr, 2015. PMID 25023926

2015 / Randomized controlled crossover trial

Substituting red meat with legumes in a TLC diet improved lipid profiles and glycemic control in participants with type 2 diabetes.

Thirty-one type 2 diabetes patients were randomized in a crossover trial to an 8-week legume-free Therapeutic Lifestyle Change (TLC) diet and an 8-week legume-based TLC diet (replacing two servings of red meat with legumes 3 days per week), separated by a 4-week washout. Compared with the control diet, the legume-based diet significantly decreased fasting blood glucose (P=0.04), fasting insulin (P=0.04), triglycerides (P=0.04), and LDL cholesterol (P=0.02). Total cholesterol decreased in both diets with no significant difference between them, and BMI, waist circumference, and systolic and diastolic blood pressure did not change significantly between diets.

Hosseinpour-Niazi S, Mirmiran P, Hedayati M, et al. Eur J Clin Nutr, 2015. PMID 25351652

2015 / Randomized controlled crossover trial

Antibacterial mouthwash use for 3 days reduced oral nitrate reduction and raised systolic blood pressure in treated hypertensive adults.

A randomized controlled crossover trial investigated the effects of 3-day antibacterial mouthwash use compared to control (water) in 15 treated hypertensive men and women. Mouthwash use led to decreased oral nitrate to nitrite reduction (P = 0.02), lower salivary nitrite (P = 0.01), higher salivary nitrate (P < 0.001), and a trend toward lower plasma nitrite (P = 0.09). In addition, mouthwash significantly increased systolic blood pressure relative to control (2.3 mm Hg; 95% CI: 0.5, 4.0; P = 0.01), with no significant effect on diastolic blood pressure (P = 0.4) or plasma cGMP (P = 0.7).

Bondonno CP, Liu AH, Croft KD, et al. Am J Hypertens, 2015. PMID 25359409

2015 / Parallel, single-blind randomized controlled trial

Brown and golden flaxseed intake reduced diastolic blood pressure in overweight adolescents but did not differentially affect lipids or glucose.

Seventy-five overweight adolescents were randomized to consume 28 g/day of brown flaxseed, golden flaxseed, or wheat bran (control) on weekdays for 11 weeks. Groups consuming brown and golden flaxseed demonstrated a significant reduction in diastolic blood pressure. Neither flaxseed variety differentially affected plasma lipids, glucose, or inflammatory profile, and all three groups showed increased TNF-α levels. The authors noted that adolescents consumed only about half the provided amount, which may have been insufficient to influence lipids, inflammation, or body composition.

Machado AM, de Paula H, Cardoso LD, et al. Nutrition, 2015. PMID 25441591

2015 / Randomized crossover controlled-feeding trial

Almond snacking lowered LDL cholesterol and central adiposity in adults with elevated cholesterol

In a randomized crossover controlled-feeding trial of 48 adults with high LDL cholesterol, consuming 1.5 oz daily of almonds for six weeks lowered non-HDL cholesterol by 6.9±2.4 mg/dL (P=0.01) and LDL cholesterol by 5.3±1.9 mg/dL (P=0.01) compared to an isocaloric muffin snack. Almond intake also decreased abdominal fat by 0.07±0.03 kg (P=0.02) and leg fat by 0.12±0.05 kg (P=0.02) without altering total weight. The control snack reduced HDL cholesterol, whereas almonds maintained baseline concentrations.

Berryman CE, West SG, Fleming JA, et al. J Am Heart Assoc, 2015. PMID 25559009

2015 / Randomized controlled trial

Daily blueberry powder reduced blood pressure and arterial stiffness in postmenopausal women.

In an eight-week trial, 48 postmenopausal women with pre- and stage 1-hypertension received 22 g daily of freeze-dried blueberry powder or control powder. Systolic blood pressure (131±17 mm Hg, P<0.05), diastolic blood pressure (75±9 mm Hg, P<0.01), and brachial-ankle pulse wave velocity (1,401±122 cm/second, P<0.01) decreased significantly from baseline in the blueberry group, along with increased nitric oxide levels (15.35±11.16 μmol/L, P<0.01). No changes occurred in the control powder group.

Johnson SA, Figueroa A, Navaei N, et al. J Acad Nutr Diet, 2015. PMID 25578927

2015 / Randomized controlled trial

Adding 100 grams of almonds daily to statin therapy reduced non-HDL cholesterol.

A randomized trial assigned 48 adults receiving ongoing statin therapy to add 100 grams of almonds daily or follow diet counseling alone for four weeks. Participants in the almond group showed a 4.9% reduction in non-HDL cholesterol compared with a 3.5% increase in the control group (p = 0.02). Non-significant reductions occurred for LDL cholesterol and triglycerides (p = 0.068 for both), while LDL particle distribution shifted from pattern A to B.

Ruisinger JF, Gibson CA, Backes JM, et al. J Clin Lipidol, 2015. PMID 25670361

2015 / Randomized crossover trial

A high-nitrate vegetable diet increased plasma nitrite and reduced systolic blood pressure.

A randomized crossover trial tested the effects of consuming high-nitrate vegetables versus avoiding them for one week in 19 healthy women. The high-nitrate diet raised plasma nitrate from 24.4 to 61.0 µmol/l and nitrite from 98 to 185 nmol/l (both P < 0.05). Resting systolic blood pressure was reduced from 107 to 103 mmHg after the high-nitrate diet (P < 0.05), whereas the control diet produced no significant changes.

Ashworth A, Mitchell K, Blackwell JR, et al. Public Health Nutr, 2015. PMID 25683748

2015 / Randomized controlled trial

A simplified high-fiber diet led to a 2.1 kg weight loss at 12 months compared to 2.7 kg with the multicomponent AHA diet in adults with metabolic syndrome.

In a randomized controlled trial, 240 adults with metabolic syndrome were assigned to a diet focused on increased fiber consumption versus the multicomponent American Heart Association (AHA) dietary guidelines. At 12 months, mean weight change was -2.1 kg (95% CI, -2.9 to -1.3 kg) in the high-fiber group versus -2.7 kg (CI, -3.5 to -2.0 kg) in the AHA group, with a mean between-group difference of 0.6 kg (CI, -0.5 to 1.7 kg). Eight participants developed diabetes (7 in high-fiber, 1 in AHA; P = 0.066), and dropout rates were 9.9% versus 12.6% (P = 0.55). Limitations noted include unknown generalizability, lack of weight maintenance assessment after sessions ended, and lack of power for dietary equivalence.

Ma Y, Olendzki BC, Wang J, et al. Ann Intern Med, 2015. PMID 25686165

2015 / Randomized controlled trial

Milled flaxseed reduced LDL cholesterol in patients with peripheral artery disease.

A double-blind trial randomized 110 patients with peripheral artery disease to foods containing 30 g of milled flaxseed (n=58) or 30 g of whole wheat (n=52) daily for 12 months. Flaxseed lowered circulating LDL cholesterol by 15% at 1 month (P=0.05), though differences between groups were not significant at 12 months (P=0.33). In participants also taking cholesterol-lowering drugs, flaxseed decreased LDL cholesterol by 8.5% at 12 months compared to a 3.0% increase with placebo (P=0.030).

Edel AL, Rodriguez-Leyva D, Maddaford TG, et al. J Nutr, 2015. PMID 25694068

2015 / Randomized crossover trial

Potassium supplementation attenuated postprandial endothelial dysfunction induced by a high-sodium meal.

In a randomized crossover trial, 39 healthy normotensive adults consumed three test meals with varying sodium and potassium contents on separate occasions. Adding 38 mmol potassium to a 65 mmol sodium meal significantly attenuated the postmeal decrease in flow-mediated dilatation compared with a low-potassium, high-sodium meal (P < 0.05). No significant differences were observed between meals for pulse wave velocity, central augmentation index, or blood pressure.

Blanch N, Clifton PM, Petersen KS, et al. Am J Clin Nutr, 2015. PMID 25787997

2015 / Single-arm pre-post intervention study

Daily tomato juice supplementation reduced waist circumference, serum cholesterol, and inflammatory adipokines in young women regardless of body fat changes.

Thirty young females with BMI >= 20 drank 280 mL of tomato juice daily (providing 32.5 mg of lycopene) for 2 months while maintaining their normal diet and exercise. Twenty-five participants completed the trial. Supplementation significantly decreased body weight, body fat, waist circumference, BMI, cholesterol, MCP-1, and thiobarbituric reactive substances, while increasing adiponectin, triglyceride, and lycopene levels. Decreases in waist circumference, cholesterol, and MCP-1 and increases in adiponectin and lycopene occurred regardless of whether participants experienced body fat reduction.

Li YF, Chang YY, Huang HC, et al. Nutrition, 2015. PMID 25837214

2015 / Randomized crossover trial

A 25% caloric restriction reduced orthostatic tolerance during lower body negative pressure, independent of bedrest.

Nine healthy young men completed four 2-week interventions (normocaloric bedrest, normocaloric ambulatory, hypocaloric bedrest, hypocaloric ambulatory) separated by 5 months to examine the effects of a 25% caloric restriction and 6° head-down bedrest. Caloric restriction showed a strong trend toward reduced basal muscle sympathetic nerve activity (22±3 vs. 14±4 burst/min, p = 0.06). Both bedrest and caloric restriction were associated with lower systolic blood pressure during lower body negative pressure (p < 0.01), but heart rate increased with bedrest and decreased with caloric restriction. Survival analysis demonstrated a significant reduction in orthostatic tolerance following caloric restriction (normocaloric finishers: 12/16; hypocaloric finishers: 6/16; p = 0.03).

Florian JP, Baisch FJ, Heer M, et al. PLoS One, 2015. PMID 25915488

2015 / Randomized crossover trial

Organic khorasan wheat improved cardiovascular risk markers in acute coronary syndrome patients.

In a randomized crossover trial, 22 acute coronary syndrome patients consumed cereal products made from organic semi-whole khorasan wheat or modern control wheat for eight weeks each. The khorasan intervention significantly lowered total cholesterol by 6.8%, LDL cholesterol by 8.1%, glucose by 8%, and insulin by 24.6% from baseline. It also reduced reactive oxygen species, tumor necrosis factor-alpha, and lipoperoxidation of circulating monocytes and lymphocytes, whereas control wheat produced no significant changes.

Whittaker A, Sofi F, Luisi ML, et al. Nutrients, 2015. PMID 25970146

2015 / Randomized crossover controlled feeding study

A high-sodium diet reduced brachial artery flow-mediated dilation similarly in both salt-sensitive and salt-resistant adults.

Ten salt-resistant and ten salt-sensitive healthy, normotensive participants completed a controlled feeding study with a run-in diet followed by a 7-day low-sodium diet (20 mmol/day) and a 7-day high-sodium diet (300 mmol/day) in random order. Brachial artery flow-mediated dilation (FMD) was lower during the high-sodium diet compared to the low-sodium diet in both groups (P < 0.001) without differing between groups (FMD: SR LS 10.6 ± 1.3%, SR HS 7.2 ± 1.5%, SS LS 12.5 ± 1.7%, SS HS 7.8 ± 1.4%). Thus, high dietary sodium impaired brachial artery FMD to a similar extent regardless of salt sensitivity.

Matthews EL, Brian MS, Ramick MG, et al. J Appl Physiol (1985), 2015. PMID 26078434

2015 / Randomized crossover trial

Daily almond intake improved diet quality but did not alter vascular function in heart patients.

A randomized crossover trial evaluated adding 85 grams of almonds daily to an NCEP Step 1 diet for 6 weeks in 45 patients with coronary artery disease. Almond supplementation raised plasma α-tocopherol by 5.8% (P ≤ 0.05) and improved intakes of fiber, calcium, magnesium, and choline. However, it did not significantly alter vascular function, blood pressure, lipids, or inflammatory markers such as C-reactive protein or tumor necrosis factor-α.

Chen CY, Holbrook M, Duess MA, et al. Nutr J, 2015. PMID 26080804

2015 / Experimental animal study and pilot clinical trial

A fasting mimicking diet promoted multi-system regeneration in mice and reduced disease biomarkers.

Cycles of a fasting mimicking diet extended lifespan, stimulated stem cell regeneration upon re-feeding, reduced visceral fat, decreased cancer incidence, and improved cognitive performance in mice. In a pilot clinical trial, three cycles of the fasting mimicking diet decreased risk factors and biomarkers associated with aging, diabetes, cardiovascular disease, and cancer without causing major adverse effects.

Brandhorst S, Choi IY, Wei M, et al. Cell Metab, 2015. PMID 26094889

2015 / Randomized crossover trial

High-saturated-fat cheese and meat diets increased HDL cholesterol compared to carbohydrates.

Fourteen overweight postmenopausal women consumed three 2-week isocaloric diets containing high-fat cheese, high-fat meat, or high carbohydrates in a randomized crossover design. Compared to the carbohydrate diet, the cheese diet increased HDL cholesterol by 5% (P = 0.012) and the meat diet increased it by 8% (P < 0.001). Total cholesterol, LDL cholesterol, and triglycerides did not differ, whereas both cheese and meat diets increased fecal fat and bile acid excretion.

NANO counterpoint →

Thorning TK, Raziani F, Bendsen NT, et al. Am J Clin Nutr, 2015. PMID 26178720

2015 / Randomized controlled trial

Two-year calorie restriction reduced cardiometabolic risk factors and thyroid hormone in nonobese adults

In a 2-year trial, 218 nonobese adults aged 21-51 years were randomized to 25% caloric restriction or ad libitum diet. The restriction group achieved 11.7% calorie reduction and sustained 10.4% weight loss. Triiodothyronine decreased significantly more in the restricted group at 12 and 24 months (P<0.001), while weight-adjusted resting metabolic rate fell significantly more at 12 months (P=0.04) but not at 24 months. Core temperature was unchanged, and cardiometabolic risk factors decreased without harming quality of life.

Ravussin E, Redman LM, Rochon J, et al. J Gerontol A Biol Sci Med Sci, 2015. PMID 26187233